Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type

ConclusionsThe applied adjuvant treatment and the tumour entity had a significant impact on the long-term QoL of TC survivors, even more than 25  years after the completion of therapy. Both RT and CT had a negative impact compared to survivors treated with RPLND, except for sexual concerns. NSGCT survivors had a lower impairment of QoL compared to seminoma survivors, except in terms of sexual concerns.Implications for Cancer SurvivorsImplications for cancer survivors are to raise awareness of aspects of long-term and late effects on QoL in TC survivors; offer supportive care, such as psycho-oncological support or lifestyle modification, if a deterioration in QoL is noticed; and avoid toxic treatment without compromising a cure whenever possible.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research